Eterna Therapeutics (ERNA) Competitors $0.22 +0.01 (+5.42%) Closing price 03:59 PM EasternExtended Trading$0.21 -0.01 (-3.70%) As of 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ERNA vs. HOWL, LVTX, OKUR, CELU, ATRA, SCYX, ITRM, ALVR, RVPH, and RNXTShould you be buying Eterna Therapeutics stock or one of its competitors? The main competitors of Eterna Therapeutics include Werewolf Therapeutics (HOWL), LAVA Therapeutics (LVTX), OnKure Therapeutics (OKUR), Celularity (CELU), Atara Biotherapeutics (ATRA), SCYNEXIS (SCYX), Iterum Therapeutics (ITRM), AlloVir (ALVR), Reviva Pharmaceuticals (RVPH), and RenovoRx (RNXT). These companies are all part of the "pharmaceutical products" industry. Eterna Therapeutics vs. Werewolf Therapeutics LAVA Therapeutics OnKure Therapeutics Celularity Atara Biotherapeutics SCYNEXIS Iterum Therapeutics AlloVir Reviva Pharmaceuticals RenovoRx Eterna Therapeutics (NASDAQ:ERNA) and Werewolf Therapeutics (NASDAQ:HOWL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, community ranking, analyst recommendations, valuation, risk and profitability. Does the MarketBeat Community prefer ERNA or HOWL? Werewolf Therapeutics received 34 more outperform votes than Eterna Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformEterna TherapeuticsN/AN/AWerewolf TherapeuticsOutperform Votes3470.83% Underperform Votes1429.17% Which has stronger earnings & valuation, ERNA or HOWL? Eterna Therapeutics has higher earnings, but lower revenue than Werewolf Therapeutics. Werewolf Therapeutics is trading at a lower price-to-earnings ratio than Eterna Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEterna Therapeutics$582K19.39-$21.67M-$8.31-0.03Werewolf Therapeutics$1.89M21.18-$37.37M-$1.66-0.54 Is ERNA or HOWL more profitable? Werewolf Therapeutics has a net margin of -578.80% compared to Eterna Therapeutics' net margin of -7,513.88%. Eterna Therapeutics' return on equity of 0.00% beat Werewolf Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Eterna Therapeutics-7,513.88% N/A -117.48% Werewolf Therapeutics -578.80%-58.83%-38.45% Does the media refer more to ERNA or HOWL? In the previous week, Eterna Therapeutics had 1 more articles in the media than Werewolf Therapeutics. MarketBeat recorded 2 mentions for Eterna Therapeutics and 1 mentions for Werewolf Therapeutics. Eterna Therapeutics' average media sentiment score of 0.00 equaled Werewolf Therapeutics'average media sentiment score. Company Overall Sentiment Eterna Therapeutics Neutral Werewolf Therapeutics Neutral Do analysts recommend ERNA or HOWL? Werewolf Therapeutics has a consensus target price of $9.00, suggesting a potential upside of 910.44%. Given Werewolf Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Werewolf Therapeutics is more favorable than Eterna Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eterna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Werewolf Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, ERNA or HOWL? Eterna Therapeutics has a beta of 4.79, meaning that its share price is 379% more volatile than the S&P 500. Comparatively, Werewolf Therapeutics has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Do insiders & institutionals have more ownership in ERNA or HOWL? 70.6% of Eterna Therapeutics shares are owned by institutional investors. Comparatively, 64.8% of Werewolf Therapeutics shares are owned by institutional investors. 4.5% of Eterna Therapeutics shares are owned by company insiders. Comparatively, 21.1% of Werewolf Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryWerewolf Therapeutics beats Eterna Therapeutics on 10 of the 16 factors compared between the two stocks. Get Eterna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ERNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ERNA vs. The Competition Export to ExcelMetricEterna TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.29M$6.68B$5.44B$7.80BDividend YieldN/A3.17%5.43%4.30%P/E Ratio-0.037.1422.1418.39Price / Sales19.39238.89389.70101.29Price / CashN/A65.6738.2034.62Price / Book0.536.266.664.18Net Income-$21.67M$142.48M$3.21B$247.71M7 Day Performance16.76%7.91%5.83%6.45%1 Month Performance-11.84%-6.03%-4.31%-3.14%1 Year Performance-87.56%-0.96%17.83%5.40% Eterna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ERNAEterna Therapeutics0.908 of 5 stars$0.22+5.4%N/A-88.2%$11.29M$582,000.00-0.0310HOWLWerewolf Therapeutics2.1464 of 5 stars$0.83-9.7%$9.00+984.6%-86.0%$37.20M$1.89M-0.5440Upcoming EarningsNews CoverageGap DownLVTXLAVA Therapeutics1.491 of 5 stars$1.40+6.6%$3.17+126.7%-49.6%$36.75M$11.98M-1.3660OKUROnKure Therapeutics2.6378 of 5 stars$2.73-5.5%$32.33+1,084.4%N/A$36.68MN/A-0.22N/ACELUCelularity0.0924 of 5 stars$1.52-2.3%N/A-50.0%$36.19M$48.20M0.00220News CoverageGap DownATRAAtara Biotherapeutics4.2455 of 5 stars$6.14-0.5%$17.75+189.1%-57.5%$35.97M$128.94M-0.24330News CoverageSCYXSCYNEXIS0.195 of 5 stars$0.92+1.7%N/A-29.0%$35.86M$3.75M-1.2460Analyst UpgradeNews CoverageGap UpITRMIterum Therapeutics1.3418 of 5 stars$1.03-4.6%$5.00+385.4%-16.1%$35.62MN/A-0.7910ALVRAlloVirN/A$6.99+4.3%N/A-60.9%$35.25MN/A-0.35110RVPHReviva Pharmaceuticals2.2521 of 5 stars$0.75-4.7%$10.00+1,241.2%-70.2%$34.85MN/A-0.675Analyst ForecastNews CoverageRNXTRenovoRx2.2031 of 5 stars$0.95-6.9%$6.00+531.6%-17.9%$34.72M$43,000.00-1.676 Related Companies and Tools Related Companies HOWL Alternatives LVTX Alternatives OKUR Alternatives CELU Alternatives ATRA Alternatives SCYX Alternatives ITRM Alternatives ALVR Alternatives RVPH Alternatives RNXT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ERNA) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eterna Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eterna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ERNA Stock Free ERNA Stock Alerts